US approves drug for rare childhood epilepsy

0
1

The U.S Food and Drug Administration on Thursday approved Zogenix’s drug to treat seizures associated with a rare form of childhood epilepsy known as Dravet syndrome. The drug, branded as Fintepla, uses a low-dose liquid solution of fenfluramine, which was used in an obesity drug combination that was later withdrawn from the market due to evidence of heart valve damage.

NO COMMENTS